Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$732
|
$688B |
14.0x |
35.8x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$152
|
$378B |
4.2x |
11.9x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$175
|
$371B |
6.5x |
14.4x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 420
|
$280B |
6.3x |
12.9x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 246
|
$242B |
3.5x |
8.8x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£100
|
$224B |
4.0x |
11.9x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$79
|
$223B |
3.5x |
8.2x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 86
|
$210B |
4.1x |
10.1x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$286
|
$202B |
5.9x |
10.3x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$438
|
$191B |
4.4x |
17.4x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$167B |
2.6x |
6.9x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$189
|
$150B |
6.3x |
19.8x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$104
|
$144B |
5.0x |
12.1x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$144B |
3.0x |
14.8x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€90
|
$128B |
2.7x |
9.1x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$484
|
$120B |
10.6x |
53.8x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£13
|
$84.7B |
2.1x |
6.0x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 233
|
$81.6B |
5.3x |
15.9x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$149
|
$71.4B |
7.7x |
18.0x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3933
|
$69.9B |
2.3x |
9.0x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 6286
|
$62.1B |
7.9x |
16.1x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€115
|
$62.0B |
2.7x |
9.4x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€20
|
$56.3B |
1.1x |
5.3x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$554
|
$54.3B |
3.8x |
10.0x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$53.7B |
3.7x |
14.7x |
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1045000
|
$50.8B |
15.3x |
38.0x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 524
|
$46.6B |
6.0x |
20.6x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1688
|
$44.9B |
7.3x |
25.4x |
Jiangsu Hengrui
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 48
|
$39.1B |
9.9x |
39.2x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$146
|
$38.0B |
2.4x |
10.2x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€37
|
$34.5B |
1.5x |
8.9x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3105
|
$34.0B |
2.7x |
14.9x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$391
|
$32.4B |
8.2x |
24.5x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$103
|
$31.2B |
4.7x |
16.1x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 50
|
$30.7B |
1.9x |
6.5x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€510
|
$30.2B |
11.4x |
129.2x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$238
|
$29.4B |
12.1x |
240.6x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€133
|
$28.6B |
4.2x |
16.2x |
BeiGene
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 146
|
$24.7B |
5.9x |
-109.3x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$164
|
$24.7B |
2.4x |
12.4x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 161100
|
$24.6B |
9.4x |
30.3x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$221
|
$24.3B |
1.8x |
10.8x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1042
|
$23.7B |
6.1x |
18.7x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 76
|
$22.7B |
5.1x |
22.1x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$22.2B |
1.5x |
5.0x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 6724
|
$22.2B |
1.4x |
6.2x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 6
|
$21.7B |
2.2x |
6.5x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$115
|
$21.1B |
2.2x |
6.3x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$325
|
$20.7B |
7.0x |
19.2x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1270
|
$19.8B |
1.6x |
7.5x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$32
|
$19.7B |
6.9x |
7.4x |
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€163
|
$19.3B |
6.3x |
22.3x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$148
|
$19.2B |
10.9x |
-88.6x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 32
|
$19.0B |
1.8x |
9.2x |
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 52
|
$18.5B |
3.3x |
9.3x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$254
|
$18.3B |
8.4x |
37.8x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5589
|
$16.8B |
15.5x |
49.1x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 205
|
$16.8B |
10.9x |
33.1x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$16.7B |
N/A |
-65.1x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€7
|
$15.0B |
1.9x |
7.7x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$144
|
$14.7B |
1.8x |
8.6x |
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€114
|
$14.5B |
3.3x |
14.0x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 23
|
$14.1B |
8.1x |
21.7x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$95
|
$13.6B |
4.9x |
15.7x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 374500
|
$13.5B |
158.1x |
334.1x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 244
|
$13.3B |
20.1x |
35.8x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$75
|
$13.2B |
3.0x |
11.2x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1463
|
$12.8B |
4.0x |
15.4x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€47
|
$12.6B |
4.9x |
13.1x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3129
|
$12.5B |
9.3x |
28.5x |
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€48
|
$12.5B |
1.6x |
7.4x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.2B |
2.2x |
16.0x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$69
|
$12.2B |
30.9x |
-13.8x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 68
|
$11.2B |
25.7x |
71.9x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$11.1B |
1.7x |
5.7x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2351
|
$10.8B |
7.5x |
28.6x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 22
|
$10.7B |
1.9x |
10.5x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1109
|
$10.6B |
2.8x |
10.3x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1969
|
$10.4B |
4.0x |
17.0x |
Biomarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$57
|
$10.4B |
3.5x |
15.3x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 254
|
$10.2B |
3.9x |
10.6x |
Sonic Healthcare
|
Australia |
Laboratory Services,
Medical Imaging & Diagnostics
|
AUD 25
|
$10.2B |
1.7x |
9.4x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$44
|
$10.0B |
3.5x |
28.3x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 868
|
$9.8B |
3.7x |
12.5x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$281
|
$9.7B |
3.3x |
6.1x |
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 20
|
$9.6B |
3.6x |
10.5x |
Ingredion
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$130
|
$9.4B |
1.3x |
7.6x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$42
|
$9.3B |
4.7x |
12.7x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 48
|
$9.3B |
6.8x |
435.2x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$100
|
$9.3B |
2.2x |
4.9x |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 21
|
$9.2B |
2.9x |
7.5x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 82
|
$9.0B |
25.7x |
-383.3x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€134
|
$9.0B |
N/A |
N/A |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$9.0B |
4.1x |
12.6x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$57
|
$8.9B |
2.0x |
20.4x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 37
|
$8.6B |
1.4x |
12.9x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$298
|
$8.5B |
4.0x |
17.7x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 302
|
$8.4B |
31.7x |
-318.6x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2158
|
$8.4B |
2.8x |
6.8x |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 23
|
$8.4B |
2.1x |
15.5x |